An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
By Representative Kilcoyne of Clinton, a petition (accompanied by bill, House, No. 1074) of Meghan Kilcoyne and others relative to cancer patient access to biomarker testing to provide appropriate therapy. Financial Services.
Bill Information
Bill Information
- Presenter:
- Meghan K. Kilcoyne
- Status:
- Referred to House Committee on Ways and Means
Bill History
| Date | Branch | Action |
|---|---|---|
| 2/16/2023 | House | Referred to the committee on Financial Services |
| 2/16/2023 | Senate | Senate concurred |
| 4/18/2023 | Joint |
|
| 4/28/2023 | Joint | Hearing rescheduled to 05/02/2023 from 10:00 AM-01:00 PM in Gardner Auditorium |
| 2/8/2024 | House | Reporting date extended to Friday May 17, 2024, pending concurrence |
| 3/28/2024 | Senate | Senate concurred |
| 5/23/2024 | House | Reported favorably by committee and referred to the committee on Health Care Financing |
| 6/20/2024 | House | Accompanied by S689 |
| 6/20/2024 | House | Committee recommended bill ought to pass and referred to the committee on House Ways and Means |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.